Incontinentia Pigmenti
Elizabeth A. Jones
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust and Division of Evolution and Genomic Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
Search for more papers by this authorDian Donnai
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust and Division of Evolution and Genomic Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
Search for more papers by this authorElizabeth A. Jones
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust and Division of Evolution and Genomic Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
Search for more papers by this authorDian Donnai
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust and Division of Evolution and Genomic Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
Search for more papers by this authorPeter Hoeger
Search for more papers by this authorVeronica Kinsler
Search for more papers by this authorAlbert Yan
Search for more papers by this authorJohn Harper
Search for more papers by this authorArnold Oranje
Search for more papers by this authorChristine Bodemer
Search for more papers by this authorMargarita Larralde
Search for more papers by this authorVibhu Mendiratta
Search for more papers by this authorDiana Purvis
Search for more papers by this authorSummary
Incontinentia pigmenti is a multisystem disorder affecting predominantly females. It is characterized by distinct cutaneous features which classically occur in four stages in the distribution of Blaschko lines: vesicular, verrucous, hyperpigmented and atrophic. These stages often occur in a temporal sequence but all stages do not necessarily occur and several stages may overlap. Additional abnormalities that commonly occur include: dental anomalies such as hypodontia or abnormally shaped teeth, peripheral neovascularization of retina and neurodevelopmental abnormalities. Incontinentia pigmenti is an X-linked dominant disorder caused by mutations in the IKBKG gene (previously known as the NEMO gene). In the majority of affected women, a recurrent deletion in the IKBKG gene is responsible and molecular diagnosis is available. Knowledge of this multisystem disorder and early diagnosis is important for clinical management, particularly because of the risk of neovascularization of retina which can result in visual loss if not detected in time.
References
- Garrod AE. Peculiar pigmentation of the skin of an infant. Trans Clin Soc Lond 1906; 39: 216.
-
Bardach M. Systematisierte Naevusbildungen bei einem eineiigen Zwillingspaar. Z Kinderheilkd 1925; 39: 542–50.
10.1007/BF02225291 Google Scholar
- Bloch B. Eigentumliche, bischer nicht beschriebene Pigmentaffektion (incontinentia pigmenti). Schweiz Med Wochenschr 1926; 7: 404–5.
-
Siemens HW. Die Melanosis corii degenerativa eine neue Pigmentdermatose. Arch Dermatol Syph (Berl) 1929; 157: 382–91.
10.1007/BF01959549 Google Scholar
- Sulzberger MB. Uber eine bischer nicht beschriebene congenitale Pigmentanomalie (IP). Arch Dermatol Syph (Berl) 1928; 154: 19–32.
- Sefiani A, Abel L, Heuertz S et al. The gene for incontinentia pigmenti is assigned to Xq28. Genomics 1989; 4: 427–9.
- Smahi A, Courtois G, Vabres P et al. Genomic rearrangement in NEMO impairs NF-B activation and is a cause of incontinentia pigmenti. Nature 2000; 405: 466–72
- Carney RG. Incontinentia pigmenti: a world statistical analysis. Arch Dermatol 1976; 112: 535–42.
- Landy SJ, Donnai D. Incontinentia pigmenti (Bloch–Sulzberger syndrome). J Med Genet 1993; 30: 53–9.
-
Sheuerle AE. Male cases of incontinentia pigmenti: case report and review. Am J Med Genet 1998; 77: 201–18.
10.1002/(SICI)1096-8628(19980518)77:3<201::AID-AJMG5>3.0.CO;2-S PubMed Web of Science® Google Scholar
- Pacheco TR, Levy M, Collyer JC et al. Incontinentia pigmenti in male patients. J Am Acad Dermatol 2006; 55: 251–5.
- Ardelean D, Pope E Incontinentia pigmenti in boys: a series and review of the literature. Pediatr Dermatol 2007; 23: 523–7.
- Fusco F, Fimiani G, Tadini G et al. Clinical diagnosis of incontinentia pigmenti in a cohort of male patients. J Am Acad Dermatol 2007; 56: 264–7.
- Fusco F, Paciolla M, Conte, MI et al. Incontinentia pigmenti: report on data from 2000 to 2013. Orphanet J Rare Dis 2014; 9: 93.
- Orphanet Report Series, Prevalence and incidence of rare diseases, June 2018 – http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf
- Curtis ARJ, Lindsay S, Boye E et al. A study of X chromosome activity in two incontinentia pigmenti families with probable linkage to Xq28. Eur J Hum Genet 1994; 2: 51–8.
- Courtois G, Smahi A, Israël A. NEMO/IKK gamma: linking NF-kappa B to human disease Trends Mol Med. 2001; 7(10): 427–30.
- Nelson DL. NEMO, NFkappaB signaling and incontinentia pigmenti. Curr Opin Genet Dev 2006; 16: 282–8.
- Ormerod AD, White MI, McKay E et al. Incontinentia pigmenti in a boy with Klinefelter's syndrome. J Med Genet 1987; 24: 439–41.
- Garcia-Dorado J, de Unamo P, Fernandez-Lopez E et al. Incontinentia pigmenti: XXY male with family history. Clin Genet 1990; 38: 128–38.
- Kenwrick S, Woffendin H, Jakins T et al. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet 2001; 69: 1210–7.
- Rashidghamat E, Hsu CK, Nanda A et al. Incontinentia pigmenti in a father and daughter. B J Derm 2016; 175: 1059–60.
- Sommer AM, Liu PH. Incontinentia pigmenti in a father and his daughter. Am Med Genet 1984; 17: 655–9.
- Emery MM, Siegfried EC, Stone MS et al. Incontinentia pigmenti: transmission from father to daughter. J Am Acad Dermatol 1993; 29: 368–72.
- Fusco F, Pescatore A, Conte MI et al. EDA-ID and IP, Two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficientcy and/or inflammation. Int Rev Immunol 2015; 34: 445–59.
- Smahi A, Courtois G, Rabia SH et al. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 2002; 11: 2371–5.
- Zonana J, Elder ME, Schneider LC et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-(NEMO). Am J Hum Genet 2000; 67: 1555–62.
-
Mansour S, Woffendin H, Mitton S et al. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet 2001; 99: 172–7.
10.1002/1096-8628(2001)9999:9999<::AID-AJMG1155>3.0.CO;2-Y CAS PubMed Web of Science® Google Scholar
- Aradhya S, Courtois G, Rajkovic A et al. Atypical forms of incontinentia pigmenti in males result from mutations of a cytosine tract in exon 10 of NEMO (IKK). Am J Hum Genet 2001; 68: 765–71.
- Dupuis-Girod S, Corradini N, Hadj-Rabia S et al. Osteopetrosis, lymphedema, anhydrotic ectodermal dysplasia and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 2002; 109: e97.
- Simmons DA, Kegel MF, Scher RK et al. Subungual tumours in incontinentia pigmenti. Arch Dermatol 1986; 122: 1431–4.
- Mascaro JM, Palon J, Vires P et al. Painful subungual keratotic tumours in incontinentia pigmenti. J Am Acad Dermatol 1985; 13: 913–18.
- Goldberg MF, Custis PH. Retinal and other manifestations of incontinentia pigmenti (Bloch–Sulzberger syndrome). Ophthalmology 1993; 100: 1645–54.
- Francois J. Incontinentia pigmenti and retinal changes. Br J Ophthalmol 1984; 68: 19–25.
- Chen CJ, Han IC, Tian J et al Extended follow-up of treated and untreated retinopathy in incontinentia pigmenti. JAMA Ophthalmol 2015; 133: 542–8.
- Minic S, Trpinac D, Obradovic M Systematic review of central nervous system anomalies in incontinentia pigmenti. Orphanet J Rare Dis 2013; 8: 25.
- Wolf NI, Kramer N, Harting I et al. Diffuse cortical necrosis in a neonate with incontinentia pigmenti and an encephalitis-like presentation. Am J Neuroradiol 2005; 26: 1580–2.
- Loh NR, Jadresic LP, Whitelaw A. A genetic cause for neonatal encephalopathy: incontinentia with NEMO mutation. Acta Paediatr 2008; 97: 379–81.
- Maingay-de Groof F, Lequin MH, Roofhooft DW et al Extensive cerebral infarction in the newborn due to incontinentia pigmenti. Eur J Paediatr Neurol 2008; 12: 284–9.
- Bryant SA, Rutledge SL. Abnormal white matter in a neurologically intact child with incontinentia pigmenti. Pediatr Neurol 2007; 36: 199–201.
- Alshenqiti A, Nashabat M, AlGhoraibi H et al. Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report. Ther Clin Risk Manag 2017; 13: 629–34.
- Godambe S, McNamara P, Rajguru M, Hellman J. Unusual neonatal presentation of incontinentia pigmenti with persistent pulmonary hypertension of the newborn: a case report. J Perinatol 2005; 25: 289–92.
- Minic S, Trpinac D, Obradovic M. Incontinentia pigmenti diagnostic criteria update. Clin Genet 2014; 85: 536–42.
- Hatchwell E, Robinson D, Crolla JA et al. X inactivation analysis in a female with hypomelanosis of Ito associated with a balanced X; 17 translocation: evidence for functional disomy of Xp. J Med Genet 1996; 33: 216–20.
- Grzeschik KH, Bornholdt D, Oeffner F et al. Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nat Genet 2007; 39: 833–5.
- Wang X, Sutton VR, Peraza-Llanes JO et al. Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia. Nat Genet 2007; 39: 836–8.
- Derry JMJ, Gormally E, Means GD et al. Mutations in a delta8-delta7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. Nat Genet 1999; 22: 286–90.
- Salamon AS, Lichtenbelt K, Cowan F et al. Clinical presentation and spectrum of neuroimaging findings in newborn infants with incontinentia pigmenti. Dev Med Child Neurol 2016; 58: 1076–84.